Lanx Closes $15 Million Series C Funding Round

Lanx (Broomfield, CO) closed a Series C financing round for $15 million. Lanx is a private spinal device company that specializes in products for fusion surgery.The latest round was led by Credit Suisse Asset Management, a new investor. Credit Suisse managed the round through one of its divisions, dubbed the Customized Fund Investment Group. Existing investors included Oakwood Medical Investors, Noro-Moseley Partners, Goldman Sachs Private Equity Opportunities Fund and Chicago Growth Partners. Hercules Technology Growth Capital also participated as a new investor. Funds from the round will be used for development and commercialization of its product line.The company's flagship product is the Timberline Lateral Fusion System. Timberline is a complete lateral access fusion system that features low profile instrumentation. Since its launch in February of last year, the device has been widely adopted by physicians for use in patients. In addition, the company's Aspen MIS Fusion System has been a hit. Aspen is designed for posterior fixation.